A NEW HOPE FOR WEIGHT CONTROL ?

Scientists are increasingly focused on retatrutide, a promising medication developed by Eli Lilly, as a potential breakthrough in body loss . Distinct from many existing approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, substances that impact appetite and blood g